alexa Is there a Role for IV Dexamethasone in Perioperative Pain Management? | Open Access Journals
ISSN: 2155-6148
Journal of Anesthesia & Clinical Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Is there a Role for IV Dexamethasone in Perioperative Pain Management?

Djalali AG*

Department of Anesthesiology, Perioperative Pain Medicine and Intensive Care, Harvard Medical School, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA

*Corresponding Author:
Dr. Djalali AG
Department of Anesthesiology
Perioperative Pain Medicine and Intensive Care
Harvard Medical School, Brigham and Women’s Hospital
75 Francis Street, Boston, MA 02115, USA
[email protected]

Received date: September 03, 2012; Accepted date: September 13, 2012; Published date: September 23, 2012

Citation: Djalali AG (2012) Is there a Role for IV Dexamethasone in Perioperative Pain Management? J Anesth Clin Res 3:e107. doi:10.4172/2155- 6148.1000e107

Copyright: © 2012 Djalali AG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Anesthesia & Clinical Research

More than twelve years after the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) declared freedom from pain as a quasi human right, treatment of post-operative pain is still a major challenge for providers caring for surgical patients [1]. Patients’ hospital experiences are strongly influenced by their perception of pain management and their provider’s competency to ease pain [2]. In spite of numerous publications “demonizing” the adverse effects of opioids, opioids deservedly remain the major pain treatment modality in our daily anesthesia practice [3]. We must admit that a true alternative to opioids is not yet found. A multimodal approach to the treatment of pain is the current and preferred concept of acute and chronic pain management. By combining opioids with other non-opioid adjuncts, such as gabapentin, pregabalin, ketamine, clonidine, etc., providers seek to reduce the opioid dose by utilizing the additive or synergistic effect of non-opioid substances [4,5]. Following the trend in the literature, a single, IV dose of dexamethasone can be added to the list of adjuncts for pain treatment.

Dexamethasone is a potent steroid with a safe record of side effects [6]. It is best known intraoperatively as an anti-inflammatory agent that reduces tissue edema due to surgical trauma, and as a proven antiemetic.

Dexamethasone’s antiemetic property is well-established. The mechanism of action is probably due to reduction of circulating inflammatory mediators that can stimulate the chemoreceptor trigger zone in brain. In addition, the antagonistic effect of dexamethasone on 5-HT receptors may explain its antiemetic capability [7,8]. Yet, the exact antiemetic mechanism of action remains elusive.

A single dose of dexamethasone has been shown to shorten recovery time from surgical procedures and reduce post-operative pain scores [9,10]. These lower scores can be explained by the fact that dexamethasone suppresses prostaglandin production and reduces postoperative tissue edema [11]. Exactly how dexamethasone reduces postoperative pain is based on assumptions that have not been thoroughly elaborated. Nevertheless, a recent meta-analysis underscored the effectiveness of single-dose dexamethasone for post-operative pain control as an adjunct to other pain medications [12].

There is an ongoing debate about the degree to which steroids, including dexamethasone, have adverse effects on patients undergoing major surgeries. One concerning effect is increased risk of surgical wound infection because steroids directly suppress the immune response and elevate a patient’s glucose level. Other rare but possible adverse effects are gastric ulceration and suppression of adrenal gland activity.

However, dosage and time of administration can mitigate some adverse effects. A single-dose of dexamethasone causes no or mild adverse effects, whereas chronic usage may create major problems. In the case of single-dose IV dexamethasone for post-operative pain control and post-operative nausea/vomiting (PONV), the side-effect profile is benign, as shown in multiple studies and meta-analysis [6,12,13]. For both indications, 8 mg of dexamethasone is superior to 4 mg, although the minimum effective dose has not yet been established. Also the time of administration matters. Dexamethasone was found to reduce post-operative pain more effectively when given at least an hour prior to surgery or prior to anesthesia induction [14].

In summary, 8 mg of dexamethasone, given shortly prior to surgery is a safe, effective, and inexpensive choice to reduce post-operative pain and (PONV) in lieu of the available data. In patients with uncontrolled diabetes, adrenal gland disorders and other endocrinopathies, dexamethasone should be used judiciously.

Further studies are necessary to establish the minimum effective dose of dexamethasone and the best timing for its application in perioperative setting.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11489
  • [From(publication date):
    September-2012 - Sep 22, 2017]
  • Breakdown by view type
  • HTML page views : 7750
  • PDF downloads :3739

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version